SymBio Pharmaceuticals Limited (4582.T)
JPY 212.0
(-1.85%)
JPY 212.0
(-1.85%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 232.03 Million JPY | -50.57% |
| 2022 | 469.37 Million JPY | 21.7% |
| 2021 | 385.68 Million JPY | -59.18% |
| 2020 | 944.92 Million JPY | 147544.38% |
| 2019 | 640 Thousand JPY | -99.88% |
| 2018 | 534.41 Million JPY | 47.19% |
| 2017 | 363.07 Million JPY | 32.8% |
| 2016 | 273.38 Million JPY | 105.25% |
| 2015 | 133.19 Million JPY | -45.63% |
| 2014 | 244.96 Million JPY | 95.62% |
| 2013 | 125.22 Million JPY | -24.05% |
| 2012 | 164.89 Million JPY | -20.52% |
| 2011 | 207.46 Million JPY | 0.0% |
| 2010 | - JPY | 0.0% |
| 2009 | - JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 128.74 Million JPY | 47.06% |
| 2024 Q1 | 172.54 Million JPY | -25.64% |
| 2024 Q2 | 87.54 Million JPY | -49.26% |
| 2023 FY | 232.03 Million JPY | -50.57% |
| 2023 Q2 | 440.05 Million JPY | -20.77% |
| 2023 Q1 | 555.4 Million JPY | 18.33% |
| 2023 Q3 | 333.78 Million JPY | -24.15% |
| 2023 Q4 | 232.03 Million JPY | -30.49% |
| 2022 Q2 | 337.46 Million JPY | -14.03% |
| 2022 Q1 | 392.54 Million JPY | 1.78% |
| 2022 FY | 469.37 Million JPY | 21.7% |
| 2022 Q4 | 469.37 Million JPY | 7.17% |
| 2022 Q3 | 437.97 Million JPY | 29.78% |
| 2021 Q1 | 964.1 Million JPY | 2.03% |
| 2021 FY | 385.68 Million JPY | -59.18% |
| 2021 Q4 | 385.68 Million JPY | -60.15% |
| 2021 Q3 | 967.84 Million JPY | -25.38% |
| 2021 Q2 | 1.29 Billion JPY | 34.53% |
| 2020 Q3 | 360.8 Million JPY | 137.54% |
| 2020 FY | 944.92 Million JPY | 147544.38% |
| 2020 Q4 | 944.92 Million JPY | 161.89% |
| 2020 Q1 | 146.09 Million JPY | 22727.97% |
| 2020 Q2 | 151.89 Million JPY | 3.97% |
| 2019 FY | 640 Thousand JPY | -99.88% |
| 2019 Q3 | 308.84 Million JPY | 30884399900.0% |
| 2019 Q1 | 157.08 Million JPY | -70.61% |
| 2019 Q2 | 1.00 JPY | -100.0% |
| 2019 Q4 | 640 Thousand JPY | -99.79% |
| 2018 Q4 | 534.41 Million JPY | 65.71% |
| 2018 Q2 | 561.75 Million JPY | 177.77% |
| 2018 Q1 | 202.24 Million JPY | -44.3% |
| 2018 FY | 534.41 Million JPY | 47.19% |
| 2018 Q3 | 322.5 Million JPY | -42.59% |
| 2017 Q4 | 363.07 Million JPY | 44.93% |
| 2017 FY | 363.07 Million JPY | 32.8% |
| 2017 Q3 | 250.51 Million JPY | -42.09% |
| 2017 Q2 | 432.56 Million JPY | -29.51% |
| 2017 Q1 | 613.65 Million JPY | 124.46% |
| 2016 FY | 273.38 Million JPY | 105.25% |
| 2016 Q1 | 440.47 Million JPY | 230.69% |
| 2016 Q4 | 273.38 Million JPY | -16.24% |
| 2016 Q3 | 326.38 Million JPY | 178.98% |
| 2016 Q2 | 116.98 Million JPY | -73.44% |
| 2015 FY | 133.19 Million JPY | -45.63% |
| 2015 Q3 | 219.83 Million JPY | -49.59% |
| 2015 Q4 | 133.19 Million JPY | -39.41% |
| 2015 Q2 | 436.07 Million JPY | 90.1% |
| 2015 Q1 | 229.39 Million JPY | -6.36% |
| 2014 Q3 | 235.65 Million JPY | -15.33% |
| 2014 Q2 | 278.33 Million JPY | -23.99% |
| 2014 FY | 244.96 Million JPY | 95.62% |
| 2014 Q1 | 366.15 Million JPY | 192.39% |
| 2014 Q4 | 244.96 Million JPY | 3.95% |
| 2013 Q3 | 126.09 Million JPY | -66.99% |
| 2013 Q4 | 125.22 Million JPY | -0.69% |
| 2013 FY | 125.22 Million JPY | -24.05% |
| 2013 Q1 | 243.44 Million JPY | 47.64% |
| 2013 Q2 | 382 Million JPY | 56.92% |
| 2012 FY | 164.89 Million JPY | -20.52% |
| 2012 Q1 | 185.79 Million JPY | -10.45% |
| 2012 Q2 | 111.2 Million JPY | -40.15% |
| 2012 Q3 | - JPY | -100.0% |
| 2012 Q4 | 164.89 Million JPY | 0.0% |
| 2011 Q2 | 236.17 Million JPY | 95.24% |
| 2011 Q3 | 95.77 Million JPY | -59.45% |
| 2011 Q4 | 207.46 Million JPY | 116.61% |
| 2011 FY | 207.46 Million JPY | 0.0% |
| 2011 Q1 | 120.96 Million JPY | 0.0% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q4 | - JPY | 0.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2009 Q4 | - JPY | 0.0% |
| 2009 Q2 | - JPY | 0.0% |
| 2009 FY | - JPY | 0.0% |
| 2008 Q4 | - JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 96.546% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.981% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 99.799% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 99.643% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | 88.433% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 99.407% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 98.648% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 99.867% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | 92.715% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 98.904% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 99.234% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 98.366% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 97.836% |
| Tsumura & Co. | 117.61 Billion JPY | 99.803% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 99.118% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 97.84% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 99.77% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 98.802% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 98.399% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 99.566% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | 88.113% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 98.889% |
| MedRx Co., Ltd | 10 Million JPY | -2220.3% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | 85.467% |
| Solasia Pharma K.K. | 122 Million JPY | -90.189% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -3552.29% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 98.863% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 99.768% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -403.92% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 99.734% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | 89.762% |